Effects of epinephrine and ritodrine in dogs with acute hyperkalemia

D. V. Follett, Robert G Loeb, S. C. Haskins, J. D. Patz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

As plasma potassium concentrations, whether normal or elevated, can be reduced by intravenous administration of either epinephrine or ritodrine, the effects of these drugs were examined during acute hyperkalemia. Six anesthetized dogs were studied every 2 wk, on 18 separate occasions. Hyperkalemia was induced by intravenous infusion of potassium chloride, resulting in plasma potassium concentrations of 9.6 ± 0.3 mEq/L (mean ± SEM), bradycardia, and idioventricular rhythm. Dogs were then given slow intravenous injections every 30 min of either saline (controls), epinephrine, or ritodrine. Epinephrine doses were 0.01, 0.1, 1.0, 10, or 100 μg/kg; ritodrine doses were 0.1, 1.0, 10, 100, or 1000 μg/kg. At the highest doses, both epinephrine and ritodrine caused clinically important decreases in plasma potassium, reducing concentrations to below 7.0 mEq/L. Ritodrine had a significantly greater effect than epinephrine. Side effects included hypertension and dysrhythmias with epinephrine, serious hypotension with ritodrine, and tachycardia with both drugs. For both drugs, the doses that caused a decrease in plasma potassium also caused an increase in heart rate and there was a correlation between plasma potassium levels and heart rate. Epinephrine and ritodrine may be useful in treating acute hyperkalemia, but cardiovascular side effects may occur. Increased heart rate could be used as an indicator of therapeutic effect and the magnitude of the increase in heart rate may be helpful in predicting the level of response.

Original languageEnglish (US)
Pages (from-to)400-406
Number of pages7
JournalAnesthesia and Analgesia
Volume70
Issue number4
StatePublished - 1990
Externally publishedYes

Fingerprint

Ritodrine
Hyperkalemia
Epinephrine
Dogs
Potassium
Heart Rate
Pharmaceutical Preparations
Potassium Chloride
Therapeutic Uses
Bradycardia
Intravenous Infusions
Tachycardia
Intravenous Injections
Intravenous Administration
Hypotension
Hypertension

Keywords

  • ions, potassium, hyperkalemia
  • pharmacology, ritodrine, hyperkalemia treatment

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Follett, D. V., Loeb, R. G., Haskins, S. C., & Patz, J. D. (1990). Effects of epinephrine and ritodrine in dogs with acute hyperkalemia. Anesthesia and Analgesia, 70(4), 400-406.

Effects of epinephrine and ritodrine in dogs with acute hyperkalemia. / Follett, D. V.; Loeb, Robert G; Haskins, S. C.; Patz, J. D.

In: Anesthesia and Analgesia, Vol. 70, No. 4, 1990, p. 400-406.

Research output: Contribution to journalArticle

Follett, DV, Loeb, RG, Haskins, SC & Patz, JD 1990, 'Effects of epinephrine and ritodrine in dogs with acute hyperkalemia', Anesthesia and Analgesia, vol. 70, no. 4, pp. 400-406.
Follett, D. V. ; Loeb, Robert G ; Haskins, S. C. ; Patz, J. D. / Effects of epinephrine and ritodrine in dogs with acute hyperkalemia. In: Anesthesia and Analgesia. 1990 ; Vol. 70, No. 4. pp. 400-406.
@article{94ba730ec07947dd92423e68ee1be9bc,
title = "Effects of epinephrine and ritodrine in dogs with acute hyperkalemia",
abstract = "As plasma potassium concentrations, whether normal or elevated, can be reduced by intravenous administration of either epinephrine or ritodrine, the effects of these drugs were examined during acute hyperkalemia. Six anesthetized dogs were studied every 2 wk, on 18 separate occasions. Hyperkalemia was induced by intravenous infusion of potassium chloride, resulting in plasma potassium concentrations of 9.6 ± 0.3 mEq/L (mean ± SEM), bradycardia, and idioventricular rhythm. Dogs were then given slow intravenous injections every 30 min of either saline (controls), epinephrine, or ritodrine. Epinephrine doses were 0.01, 0.1, 1.0, 10, or 100 μg/kg; ritodrine doses were 0.1, 1.0, 10, 100, or 1000 μg/kg. At the highest doses, both epinephrine and ritodrine caused clinically important decreases in plasma potassium, reducing concentrations to below 7.0 mEq/L. Ritodrine had a significantly greater effect than epinephrine. Side effects included hypertension and dysrhythmias with epinephrine, serious hypotension with ritodrine, and tachycardia with both drugs. For both drugs, the doses that caused a decrease in plasma potassium also caused an increase in heart rate and there was a correlation between plasma potassium levels and heart rate. Epinephrine and ritodrine may be useful in treating acute hyperkalemia, but cardiovascular side effects may occur. Increased heart rate could be used as an indicator of therapeutic effect and the magnitude of the increase in heart rate may be helpful in predicting the level of response.",
keywords = "ions, potassium, hyperkalemia, pharmacology, ritodrine, hyperkalemia treatment",
author = "Follett, {D. V.} and Loeb, {Robert G} and Haskins, {S. C.} and Patz, {J. D.}",
year = "1990",
language = "English (US)",
volume = "70",
pages = "400--406",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Effects of epinephrine and ritodrine in dogs with acute hyperkalemia

AU - Follett, D. V.

AU - Loeb, Robert G

AU - Haskins, S. C.

AU - Patz, J. D.

PY - 1990

Y1 - 1990

N2 - As plasma potassium concentrations, whether normal or elevated, can be reduced by intravenous administration of either epinephrine or ritodrine, the effects of these drugs were examined during acute hyperkalemia. Six anesthetized dogs were studied every 2 wk, on 18 separate occasions. Hyperkalemia was induced by intravenous infusion of potassium chloride, resulting in plasma potassium concentrations of 9.6 ± 0.3 mEq/L (mean ± SEM), bradycardia, and idioventricular rhythm. Dogs were then given slow intravenous injections every 30 min of either saline (controls), epinephrine, or ritodrine. Epinephrine doses were 0.01, 0.1, 1.0, 10, or 100 μg/kg; ritodrine doses were 0.1, 1.0, 10, 100, or 1000 μg/kg. At the highest doses, both epinephrine and ritodrine caused clinically important decreases in plasma potassium, reducing concentrations to below 7.0 mEq/L. Ritodrine had a significantly greater effect than epinephrine. Side effects included hypertension and dysrhythmias with epinephrine, serious hypotension with ritodrine, and tachycardia with both drugs. For both drugs, the doses that caused a decrease in plasma potassium also caused an increase in heart rate and there was a correlation between plasma potassium levels and heart rate. Epinephrine and ritodrine may be useful in treating acute hyperkalemia, but cardiovascular side effects may occur. Increased heart rate could be used as an indicator of therapeutic effect and the magnitude of the increase in heart rate may be helpful in predicting the level of response.

AB - As plasma potassium concentrations, whether normal or elevated, can be reduced by intravenous administration of either epinephrine or ritodrine, the effects of these drugs were examined during acute hyperkalemia. Six anesthetized dogs were studied every 2 wk, on 18 separate occasions. Hyperkalemia was induced by intravenous infusion of potassium chloride, resulting in plasma potassium concentrations of 9.6 ± 0.3 mEq/L (mean ± SEM), bradycardia, and idioventricular rhythm. Dogs were then given slow intravenous injections every 30 min of either saline (controls), epinephrine, or ritodrine. Epinephrine doses were 0.01, 0.1, 1.0, 10, or 100 μg/kg; ritodrine doses were 0.1, 1.0, 10, 100, or 1000 μg/kg. At the highest doses, both epinephrine and ritodrine caused clinically important decreases in plasma potassium, reducing concentrations to below 7.0 mEq/L. Ritodrine had a significantly greater effect than epinephrine. Side effects included hypertension and dysrhythmias with epinephrine, serious hypotension with ritodrine, and tachycardia with both drugs. For both drugs, the doses that caused a decrease in plasma potassium also caused an increase in heart rate and there was a correlation between plasma potassium levels and heart rate. Epinephrine and ritodrine may be useful in treating acute hyperkalemia, but cardiovascular side effects may occur. Increased heart rate could be used as an indicator of therapeutic effect and the magnitude of the increase in heart rate may be helpful in predicting the level of response.

KW - ions, potassium, hyperkalemia

KW - pharmacology, ritodrine, hyperkalemia treatment

UR - http://www.scopus.com/inward/record.url?scp=0025063264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025063264&partnerID=8YFLogxK

M3 - Article

C2 - 2316882

AN - SCOPUS:0025063264

VL - 70

SP - 400

EP - 406

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -